RxDoctor Payments Data

Thomas Atkinson, MD

Allergy & Immunology · Birmingham, ALNPI 1508853631

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,697 of the $52,802 with a category attached, or 77.1%. It is spread thinly across 16 manufacturers, the largest accounting for just 21.0%.

$52,802in general payments, 2019–2025

Across 59 payments — averaging $894.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharming Healthcare, Inc.$11K
  • GSK$10K
  • AstraZeneca$8K
  • Regeneron$8K
  • Aquestive Therapeutics, Inc.$6K
  • CSL Behring$5K
  • plus $5K from 10 others
$102,141in research payments, 2019–2025

Across 75 payments — averaging $1361.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shire North American Group Inc$54K
  • Takeda Pharmaceuticals U.S.A., Inc.$48K

What the payments were for

  • Consulting fees$40,69777%
  • Speaking & faculty fees$8,18015%
  • Travel & lodging$2,5785%
  • Food & beverage$1,3473%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,802 in reported general payments places this provider in the 85th percentile of 30 allergy & immunology providers in Alabama.

See all allergy & immunology providers in Alabama

Medicare billing

Part B allowed, 2024
$13,250
Medicare patients
158
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →